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Objectives: The aim of our study was to identify the factors that determined whether
a patient underwent surgery and its impact on patient outcome.
Methods: A retrospective evaluation of the records of all patients diagnosed with
resectable stages I and II non-small cell lung cancer between 1990 and 1998 at the
University of Arkansas and Veterans Administration Hospitals were included in the
study. Demographic, clinical, pathologic, and outcome data were captured. Analysis
was conducted to identify prognostic factors as well as factors leading to surgical
treatment disparities.
Results: A total of 551 patients were included; 490 (89%) were men, 480 (87%)
were white, and 315 (57%) were aged 65 years. Median follow-up of these
patients was 24 months (1-109 months). Surgery was performed on 455 patients
(82.6%); 26 patients received nonsurgical treatment including chemotherapy, radi-
ation therapy, or both, and 70 patients did not receive any type of treatment. A
univariate analysis revealed that age, race, sex, and forced expiratory volume in the
first second were significantly different between the surgery and no surgery groups.
However, a multivariate analysis showed that age, forced expiratory volume in 1 second,
and hemoglobin were significantly different between both groups. The median overall
survival was 45.5 months (1-109 months) for the surgically treated patients compared
with 12.0 months (1-86 months) for those who did not undergo surgery (P  .0001).
Conclusion: Elderly patients with early-stage non–small cell lung cancer are less
likely to undergo a potentially curative surgical resection. Racial and sex disparities
may be due to other comorbidities.
It is estimated that 169,500 Americans will be given a diagnosis of lungcancer in 2001, and 157,400 persons will succumb to this disease.1 A 5-yearsurvival of less than 15%, combined with the high incidence, makes lungcancer the leading cause of cancer deaths in the United States. Differenttherapeutic modalities are used in the management of lung cancer, depend-ing on the tumor stage and the patient’s clinical status.
Surgical resection remains the preferred therapeutic modality for early stages of
non–small cell lung cancer (NSCLC), especially stages I and II, yet one third to one
half of these patients die within 5 years of diagnosis.2-5 Furthermore, many patients
with early stages of NSCLC do not undergo tumor resection because of comorbidi-
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ties or patient or physician preference. Patients who are not
treated with surgical intervention usually have worse out-
comes. Therefore the reasons for disparities in the treatment
modality should always be revisited, especially in light of
recent advances in therapeutic interventions.
This article reports the disparities in undergoing surgical
resection for stage I and II NSCLC and the differences
between patients treated with surgical resection and those
who did not have an operation.
Patients and Methods
Patient Selection
This study included all patients with stage I and II NSCLC be-
tween 1991 and 1998. All of these patients were treated at the
University of Arkansas Hospital and the Veterans Administration
Hospital.
Study Design
Data were collected by means of a retrospective review of medical
records, tumor registry records, pathology reports and slides, and
radiology reports. The data collected included patient characteris-
tics, such as age, race, sex, date of diagnosis, tumor site, type of
treatment, type of relapse or recurrence, and cause of death. Other
tumor data collected included histologic subtype and grade, tumor
margins, tumor size, number of lymph nodes sampled, number of
positive lymph nodes, and pathologic TNM staging for patients
who underwent an operation. For patients who did not undergo an
operation, the clinical staging was used. Clinical staging included
computed tomographic scanning of the chest in all patients and
computed tomographic scanning of the brain, liver, and adrenals
and bone scanning when clinically indicated. Hemoglobin level,
albumin level, and forced expiratory volume in 1 second (FEV1) at
the time of diagnosis were also included.
Statistical Analysis
Patient demographics and medical characteristics were summa-
rized with descriptive statistics (ie, percentages, medians, and
ranges). Overall survival estimates for each group were obtained
by using the Kaplan-Meier (product-limit) methodology, and sur-
vival distributions were compared by using log-rank tests. Demo-
graphic, clinical, laboratory, and pathologic factors were compared
between the 2 groups. Factors significantly associated with the
outcome were included in a Cox proportional hazards model. All
analyses were performed with SAS/STAT software, version 7
(SAS Institute Inc, Cary, NC). A comparison between the charac-
teristics of the group of patients undergoing surgical resection and
the group of patients not undergoing resection was conducted by
using a logistic regression model to determine significant differ-
ences. Significant variables were entered into a multivariate model
analysis to identify the interaction between these variables.
TABLE 1. Patient characteristics (n  551)
Characteristics No. (%)
Age (y)
65 236 (42.8)
65 315 (57.2)
Sex
Male 490 (88.9)
Female 61 (11.1)
Race
White 480 (87.1)
African American 70 (12.7)
Disease stage
I 457 (82.9)
II 94 (17.1)
Surgical resection
Yes 455 (82.6)
No 96 (17.4)
TABLE 2. Comparison between patients who underwent
surgical resection for NSCLC and those who did not un-
dergo surgical resection
Variable
Surgical
resection
No
surgical
resection P value
Age (y)
65 205 31 .02
65 250 65
Race
White 405 75 .01
African American 49 21
Sex
Male 411 79 .02
Female 44 17
Disease stage
I 380 77 .4
II 75 19
Median FEV1 (L) 2 1.2 .0001
Median hemoglobin level (g/dL) 13.8 13.5 .09
Figure 1. Kaplan-Meier cumulative survival plot for overall sur-
vival.
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Results
Five hundred fifty-one patients were included in this study.
The median age of these patients was 67 years (range, 39-83
years), 89% were men (which was a result of the large
proportion of VA patients), and 87% were white. Median
follow-up was 24 months (range, 1-109 months). Patient
characteristics are listed in Table 1. Four hundred fifty-five
(82.6%) patients underwent surgical resection of their tu-
mors, and 96 (17.4%) patients did not undergo surgical
resection. The reasons for not undergoing an operation were
poor pulmonary function test results (n  70), debilitating
medical problems (n 15), and patient refusal (n 11). Of
the group not undergoing an operation, 70 patients received
no treatment for their cancer. The remaining 26 patients had
various treatments, including chemotherapy in 12 patients,
radiation therapy in 2 patients, and combined chemotherapy
and radiation in 13 patients. The comparison between the
group undergoing an operation and the group not undergo-
ing an operation revealed that older patients (65 years)
were less likely to undergo surgical intervention compared
with younger patients (79% vs 87%, P  .02). In addition,
women were less likely to receive surgical treatment than
men (72% vs 84%, P  .02; Table 2).
Analysis of the race data revealed that African American
subjects were less likely to undergo surgical intervention
when compared with white subjects (70% vs 84%, P 
.001). Analysis combining sex and race revealed that Afri-
can American men were less likely to undergo an operation
(70% vs 86%, P  .004), but there was no difference
between African American women and white women. Pa-
tients who underwent surgical intervention had higher FEV1
values than the group of patients who did not (2 vs 1.2 L,
P  .0001). There were no differences between the groups
undergoing and not undergoing surgical treatment regarding
stage and hemoglobin level. However, when a multivariate
analysis including these variables was performed, only age,
hemoglobin level, and FEV1 were significant factors (Table
3).
The median survival of patients who underwent an op-
eration was 45.5 months (range, 1-109 months) compared
with 12 months (range, 1-86 months) for the group of
patients who did not (P  .0001, Figure 1).
A univariate analysis of race, age, sex, stage, hemoglobin
level, and FEV1 revealed that age, stage, hemoglobin level,
and FEV1 had a significant correlation with survival (Table
4).
A multivariate analysis confirmed all the latter factors to
be independent predictors for overall survival (Table 5).
Discussion
Surgical resection is the gold standard treatment for stage I
and II NSCLC. Patients who do not undergo surgical resec-
tion have a worse outcome. The results of this study are
consistent with this known fact. Although the majority of
patients underwent an operation, 17.4% did not, which is in
line with reported resection rates of 5% to 32%.2,6
Elderly patients are less likely to receive potentially
curative surgical treatment for different cancers,7 which
might be due to comorbidities and many other socioeco-
nomic factors. Age disparity was apparent in our study, with
fewer operations performed on older patients, leading to
worse outcomes in these patients. Although age should not
be a reason for offering less than standard therapy to pa-
tients, aggressive invasive therapy might not be possible in
TABLE 3. Results of logistic regression modeling for patients undergoing surgical resection versus those not undergoing
resection
Variable
Parameter
estimate (SE)
Odds ratio
(95% CI) 2 (P value)
Age, y (65 vs 65) 0.66 (0.26) 1.93 (1.16-3.20) 6.41 (.01)
Hemoglobin level, g/dL (10 vs 10) 1.49 (0.27) 4.4 (2.59-7.52) 29.93 (.0001)
FEV1, L (1 vs 1) 1.2 (0.26) 3.33 (1.98-5.59) 20.71 (.0001)
TABLE 4. Univariate analysis of different variables and
overall survival
Variable Overall survival P value
Median age (y)
65 46.2 .0001
65 26.0
Sex
Male 33.2 .98
Female 30.6
Race
White 33.3 .5
African American 31.9
Disease stage
I 38.0 .0001
II 16.2
Surgical resection
Yes 45.5 .0001
No 12.0
Hemoglobin level (g/dL)
10 39.3 .0001
10 20.2
FEV1 (L)
1 37.8 .0001
1 16.3
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many elderly patients.8 The resection rate in our older group
compares favorably with that in the reported literature. The
evolution of video-assisted surgery and lung volume-reduc-
ing surgery might increase the number of elderly patients
undergoing surgical resection.
Racial disparities in the management of cancers have
been reported. For example, African Americans were re-
ported to have less operations for colorectal cancers, even
after adjusting for age, comorbidities, and tumor stage.9 The
reasons for racial disparities might be due in part to patient
preference or difficulty in communicating and not primarily
because of racial discrimination.10-12 However, reports of
racial disparities in the management of early-stage NSCLC
focused on elderly patients (Medicare data) and did not
include other important demographic and clinical fac-
tors.6,13 In this study the apparent racial disparity in the
univariate analysis was not an independent predictor of
treatment when adjusted for age, pulmonary function test
results, and hemoglobin levels. This means, at least in this
study, that there are other reasons for racial disparity. Fur-
thermore, overall survival was similar for both races, which
also further confirmed the lack of significant racial discrim-
ination.
Our results did not show any sex-based difference in the
management of these patients and no difference in survival
between men and women.
As expected, patients with poor pulmonary function test
results were less likely to undergo an operation. The use of
volume-reduction surgery and video-assisted surgery also
might increase the number of patients with limited pulmo-
nary function undergoing surgical treatment.
Anemia was reported to be an independent prognostic
factor for patients with stage I and II NSCLC who under-
went surgical resection.14 In this study patients with anemia
also seemed to have less chance of undergoing an operation
and shorter survival.
Finally, disparity in the management of cancer is com-
plicated by various demographic, socioeconomic, and clin-
ical factors. Physicians are encouraged to look at the pat-
terns of their practice to minimize any possible remediable
disparity.
We thank Mohammed Hussain, MD, and Pat Coke, CRA, for
their help in data collection and Ms Nancy Crossen for her help in
manuscript preparation.
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TABLE 5. Results of Cox proportional hazards model for overall survival
Variable
Parameter
estimate (SE)
Hazard ratio
(95% CI)
Wald 2 (P
value)
Surgical resection 1.4 (0.13) 0.25 (0.19-0.32) 113.36 (.0001)
Age 0.49 (0.12) 1.63 (1.3-2.05) 17.48 (.0001)
Disease stage 0.53 (0.14) 1.69 (1.29-2.23) 14.02 (.0002)
Hemoglobin level 0.76 (0.13) 0.47 (0.36-0.6) 33.64 (.0001)
FEV1 0.3 (0.13) 0.74 (0.57-0.95) 5.52 (.02)
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